Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 90: Lowenstein Jenson medium
Growth Conditions
Temperature: 37.0°C
Name of Depositor
Wallace Laboratories
Chain of Custody
ATCC <<--Wallace Laboratories<<--Inst. Pasteur
References
Berger FM, et al. Process for preparing vaccine adjuvant. US Patent 4,036,953 dated Jul 19 1977
